Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV, Experimental Human Pneumococcal Challenge (EHPC) Model to Investigate Streptococcus Pneumoniae Serotype 3 (SPN3) Colonisation Following PCV15, a Double Blind Randomised Controlled Trial (DBRCT) in Healthy Participants Aged 18 - 50 Years in the UK.

NCT06731374 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT06731374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06731374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV, Experimental Human Pneumococcal Challenge (EHPC) Model to Investigate Streptococcus Pneumoniae Serotype 3 (SPN3) Colonisation Following PCV15, a Double Blind Randomised Controlled Trial (DBRCT) in Healthy Participants Aged 18 - 50 Years in the UK.
Lead sponsor
University of Oxford
Phase
Phase 4
Overall status
Recruiting
Start date
February 24, 2025
Completion date
December 31, 2026
Enrollment
106 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pneumococcal carriage, pneumococcal disease